TY - JOUR
T1 - Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps
AU - Marsh, David G.
AU - Norman, Philip S.
AU - Roebber, Marianne
AU - Lichtenstein, Lawrence M.
N1 - Funding Information:
From the Laboratory of the Howard Hughes Medical Institute and the Division of Clinical Immunology, Johns Hopkins University School of Medicine at Good Samaritan Hospital, Baltimore, Md. This study was funded by NIH grants AI 09565, AI 08270. and AI 10304. Publication No. 45 I, O’Neill Research Laboratories, tan Hospital. Received for publication May 22, 198 1. Accepted for publication Sept. 10, 198 1. Reprint requests to: Dr. David G. Marsh, Good Samaritan Hospi-tal. 5601 Loch Raven Blvd., Baltimore, MD 21239.
PY - 1981/12
Y1 - 1981/12
N2 - We have devised a new process for modifying heat-labile allergens, which employs a sequential "two-step" incubation at temperatures of 10° C and 30° to 32° C. This process was found to produce effective ragweed "allergoids" with low allergenicity and good immunogenicity, which makes them useful for the therapy of allergic humans. Modification with formaldehyde produced derivatives ("formallergoids") that were about 10-fold less allergenic in allergic humans (as measured by leukocyte histamine-release assay), and similarly or more immunogenic in guinea pigs, than glutaraldehyde-modified allergens ("glutarallergoids"). Further analysis by RAST inhibition showed that a ragweed formallergoid was sixfold less reactive than a glutarallergoid with a pool of human IgE antibodies. However, the formallergoid had retained the ability to induce a wide array of antibodies against native ragweed antigens, since rabbit anti-formallergoid serum was able to recognize at least 12 different ragweed antigens, including AgE. Gel-filtration experiments showed that both the formallergoid and glutarallergoid materials contained polymers having apparent molecular weights distributed around 260,000 and 230,000 daltons, respectively (approximate range 30,000 to 900,000 daltons). Our studies provide the immunochemical basis for the use of these allergoids in the therapy of allergic humans.
AB - We have devised a new process for modifying heat-labile allergens, which employs a sequential "two-step" incubation at temperatures of 10° C and 30° to 32° C. This process was found to produce effective ragweed "allergoids" with low allergenicity and good immunogenicity, which makes them useful for the therapy of allergic humans. Modification with formaldehyde produced derivatives ("formallergoids") that were about 10-fold less allergenic in allergic humans (as measured by leukocyte histamine-release assay), and similarly or more immunogenic in guinea pigs, than glutaraldehyde-modified allergens ("glutarallergoids"). Further analysis by RAST inhibition showed that a ragweed formallergoid was sixfold less reactive than a glutarallergoid with a pool of human IgE antibodies. However, the formallergoid had retained the ability to induce a wide array of antibodies against native ragweed antigens, since rabbit anti-formallergoid serum was able to recognize at least 12 different ragweed antigens, including AgE. Gel-filtration experiments showed that both the formallergoid and glutarallergoid materials contained polymers having apparent molecular weights distributed around 260,000 and 230,000 daltons, respectively (approximate range 30,000 to 900,000 daltons). Our studies provide the immunochemical basis for the use of these allergoids in the therapy of allergic humans.
UR - http://www.scopus.com/inward/record.url?scp=0019865908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019865908&partnerID=8YFLogxK
U2 - 10.1016/0091-6749(81)90199-8
DO - 10.1016/0091-6749(81)90199-8
M3 - Article
C2 - 6171586
AN - SCOPUS:0019865908
SN - 0091-6749
VL - 68
SP - 449
EP - 459
JO - The Journal of allergy and clinical immunology
JF - The Journal of allergy and clinical immunology
IS - 6
ER -